Astragaloside Ⅳ negatively regulates Gpr97-TPL2 signaling to protect against hyperhomocysteine-exacerbated sepsis associated acute kidney injury.

MLA

Xu, Jingge, et al. “Astragaloside Ⅳ Negatively Regulates Gpr97-TPL2 Signaling to Protect against Hyperhomocysteine-Exacerbated Sepsis Associated Acute Kidney Injury.” Phytomedicine, vol. 125, Mar. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.phymed.2024.155346.

APA

Xu, J., Zhang, Z., Ren, D., Liu, L., Xing, H., Wang, D., Wu, Y., Zhang, Y., Chen, Q., & Wang, T. (2024). Astragaloside Ⅳ negatively regulates Gpr97-TPL2 signaling to protect against hyperhomocysteine-exacerbated sepsis associated acute kidney injury. Phytomedicine, 125, N.PAG. https://doi.org/10.1016/j.phymed.2024.155346

Chicago

Xu, Jingge, Zhiyu Zhang, Dongwen Ren, Luokun Liu, Haitao Xing, Dan Wang, Yuzheng Wu, Yi Zhang, Qian Chen, and Tao Wang. 2024. “Astragaloside Ⅳ Negatively Regulates Gpr97-TPL2 Signaling to Protect against Hyperhomocysteine-Exacerbated Sepsis Associated Acute Kidney Injury.” Phytomedicine 125 (March): N.PAG. doi:10.1016/j.phymed.2024.155346.